Characterization	0	15
of	17	18
a	20	20
lipopolysaccharide	22	39
-	40	40
targeted	41	48
monoclonal	50	59
antibody	61	68
and	70	72
its	74	76
variable	78	85
fragments	87	95
as	97	98
candidates	100	109
for	111	113
prophylaxis	115	125
against	127	133
the	135	137
obligate	139	146
intracellular	148	160
bacterial	162	170
pathogen	172	179
Coxiella	181	188
burnetii	190	197
.	198	198

Our	200	202
previous	204	211
study	213	217
demonstrated	219	230
that	232	235
treatment	237	245
of	247	248
Coxiella	250	257
burnetii	259	266
with	268	271
the	273	275
phase	277	281
I	283	283
lipopolysaccharide	285	302
(	304	304
PI	305	306
-	307	307
LPS	308	310
)	311	311
-	312	312
targeted	313	320
monoclonal	322	331
antibody	333	340
(	342	342
MAb	343	345
)	346	346
1E4	348	350
significantly	352	364
inhibited	366	374
C	376	376
.	377	377
burnetii	379	386
infection	388	396
in	398	399
mice	401	404
,	405	405
suggesting	407	416
that	418	421
1E4	423	425
is	427	428
a	430	430
protective	432	441
MAb	443	445
.	446	446

To	448	449
determine	451	459
whether	461	467
passive	469	475
transfer	477	484
of	486	487
antibodies	489	498
(	500	500
Abs	501	503
)	504	504
can	506	508
provide	510	516
protection	518	527
against	529	535
C	537	537
.	538	538
burnetii	540	547
natural	549	555
infection	557	565
,	566	566
we	568	569
examined	571	578
if	580	581
passive	583	589
transfer	591	598
of	600	601
1E4	603	605
would	607	611
protect	613	619
SCID	621	624
mice	626	629
against	631	637
C	639	639
.	640	640
burnetii	642	649
aerosol	651	657
infection	659	667
.	668	668

The	670	672
results	674	680
indicated	682	690
that	692	695
1E4	697	699
conferred	701	709
significant	711	721
protection	723	732
against	734	740
aerosolized	742	752
C	754	754
.	755	755
burnetii	757	764
,	765	765
suggesting	767	776
that	778	781
1E4	783	785
may	787	789
be	791	792
useful	794	799
for	801	803
preventing	805	814
C	816	816
.	817	817
burnetii	819	826
natural	828	834
infection	836	844
.	845	845

To	847	848
further	850	856
understand	858	867
the	869	871
mechanisms	873	882
of	884	885
1E4	887	889
-	890	890
mediated	891	898
protection	900	909
and	911	913
to	915	916
test	918	921
the	923	925
possibility	927	937
of	939	940
using	942	946
humanized	948	956
1E4	958	960
to	962	963
prevent	965	971
C	973	973
.	974	974
burnetii	976	983
infection	985	993
,	994	994
we	996	997
examined	999	1006
whether	1008	1014
the	1016	1018
Fab	1020	1022
fragment	1024	1031
of	1033	1034
1E4	1036	1038
(	1040	1040
Fab1E4	1041	1046
)	1047	1047
,	1048	1048
a	1050	1050
recombinant	1052	1062
murine	1064	1069
single	1071	1076
-	1077	1077
chain	1078	1082
variable	1084	1091
fragment	1093	1100
(	1102	1102
muscFv1E4	1103	1111
)	1112	1112
,	1113	1113
and	1115	1117
a	1119	1119
humanized	1121	1129
single	1131	1136
-	1137	1137
chain	1138	1142
variable	1144	1151
fragment	1153	1160
(	1162	1162
huscFv1E4	1163	1171
)	1172	1172
retained	1174	1181
the	1183	1185
ability	1187	1193
of	1195	1196
1E4	1198	1200
to	1202	1203
inhibit	1205	1211
C	1213	1213
.	1214	1214
burnetii	1216	1223
infection	1225	1233
.	1234	1234

The	1236	1238
results	1240	1246
indicated	1248	1256
that	1258	1261
Fab1E4	1263	1268
,	1269	1269
muscFv1E4	1271	1279
,	1280	1280
and	1282	1284
huscFv1E4	1286	1294
were	1296	1299
able	1301	1304
to	1306	1307
inhibit	1309	1315
C	1317	1317
.	1318	1318
burnetii	1320	1327
infection	1329	1337
in	1339	1340
mice	1342	1345
but	1347	1349
that	1351	1354
their	1356	1360
ability	1362	1368
to	1370	1371
inhibit	1373	1379
C	1381	1381
.	1382	1382
burnetii	1384	1391
infection	1393	1401
was	1403	1405
lower	1407	1411
than	1413	1416
that	1418	1421
of	1423	1424
1E4	1426	1428
.	1429	1429

In	1431	1432
addition	1434	1441
,	1442	1442
treatment	1444	1452
of	1454	1455
C	1457	1457
.	1458	1458
burnetii	1460	1467
with	1469	1472
Fab1E4	1474	1479
,	1480	1480
muscFv1E4	1482	1490
,	1491	1491
or	1493	1494
huscFv1E4	1496	1504
can	1506	1508
block	1510	1514
C	1516	1516
.	1517	1517
burnetii	1519	1526
infection	1528	1536
of	1538	1539
macrophages	1541	1551
.	1552	1552

Interestingly	1554	1566
,	1567	1567
treatment	1569	1577
of	1579	1580
C	1582	1582
.	1583	1583
burnetii	1585	1592
with	1594	1597
huscFv1E4	1599	1607
can	1609	1611
significantly	1613	1625
reduce	1627	1632
C	1634	1634
.	1635	1635
burnetii	1637	1644
infectivity	1646	1656
in	1658	1659
human	1661	1665
macrophages	1667	1677
.	1678	1678

This	1680	1683
report	1685	1690
provides	1692	1699
the	1701	1703
first	1705	1709
evidence	1711	1718
to	1720	1721
demonstrate	1723	1733
that	1735	1738
the	1740	1742
humanized	1744	1752
variable	1754	1761
fragments	1763	1771
of	1773	1774
an	1776	1777
LPS	1779	1781
-	1782	1782
specific	1783	1790
MAb	1792	1794
can	1796	1798
neutralize	1800	1809
C	1811	1811
.	1812	1812
burnetii	1814	1821
infection	1823	1831
and	1833	1835
appears	1837	1843
to	1845	1846
be	1848	1849
a	1851	1851
promising	1853	1861
step	1863	1866
toward	1868	1873
the	1875	1877
potential	1879	1887
use	1889	1891
of	1893	1894
a	1896	1896
humanized	1898	1906
MAb	1908	1910
as	1912	1913
emergency	1915	1923
prophylaxis	1925	1935
against	1937	1943
C	1945	1945
.	1946	1946
burnetii	1948	1955
exposure	1957	1964
.	1965	1965
